Volume 27, Issue 3 pp. 250-257
Article
Full Access

In vitro t lymphocyte proliferative response to yersinia enterocolitica in reiter's syndrome

Michael B. Brenner MD

Michael B. Brenner MD

Department of Medicine, UCLA School of Medicine and Veterans Administration, Wadsworth Medical Center, Los Angeles, California.

Search for more papers by this author
Shigeto Kobayashi MD

Shigeto Kobayashi MD

Department of Medicine, UCLA School of Medicine and Veterans Administration, Wadsworth Medical Center, Los Angeles, California.

Search for more papers by this author
Craig W. Wiesenhutter MD

Craig W. Wiesenhutter MD

Department of Medicine, UCLA School of Medicine and Veterans Administration, Wadsworth Medical Center, Los Angeles, California.

Search for more papers by this author
Arthur K. Huberman MD

Arthur K. Huberman MD

Department of Medicine, UCLA School of Medicine and Veterans Administration, Wadsworth Medical Center, Los Angeles, California.

Search for more papers by this author
Peter Bales MD

Peter Bales MD

Department of Medicine, UCLA School of Medicine and Veterans Administration, Wadsworth Medical Center, Los Angeles, California.

Search for more papers by this author
David T. Y. Yu MD

David T. Y. Yu MD

Department of Medicine, UCLA School of Medicine and Veterans Administration, Wadsworth Medical Center, Los Angeles, California.

Search for more papers by this author
First published: March 1984
Citations: 22

Abstract

We assessed the in vitro T lymphocyte tritiated thymidine (3HTdr) incorporation response of Reiter's patients in the United States to a serotype 3 strain of Yersinia enterocolitica. The mean 3HTdr incorporation response to the formalin killed form of this strain was 27,409 ± 5,488 counts per minute for 14 HLA-B27 positive Reiter's patients compared with 5,414 ± 3,490 cpm for a control group of 11 HLA-B27 positive normal individuals (P < 0.0005). This high response in Reiter's patients was observed with the formalin killed form of Y enterocolitica serotype 3, but not with a heat killed form or a rough mutant form derived from the same bacterial strain. Further, Y enterocolitica of a different serotype (serotype 8) which is not associated with reactive arthritis failed to induce the high proliferative response observed with the serotype 3 strain. This response indicates that T lymphocytes from spontaneous Reiter's patients are capable of recognizing and proliferating to determinant(s) on the formalin killed form of Y enterocolitica serotype 3. Since this bacterium is associated with Reiter's syndrome in Europe but not the United States, these data are consistent with the possibility that our patients have previously encountered these or similar determinants through unrecognized infection with other microorganisms.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me